Vaginal Mesh Complications

On 15 February 2017, the Senate opened an inquiry on The number of women in Australia who have had transvaginal mesh implants and related matters.

Click on the links below to access USANZ's submission and attachments.

USANZ Submission

Attachment 1: USANZ Position Statement on the Use of Mid-Urethral Slings (MUS)
Attachment 2: IUGA Patient Information Sheet, Mid Urethral Sling
Attachment 3: UGSA draft report for the Senate Community Affairs Reference Committee
Attachment 4: USANZ Patient Information Sheet on “Treatment of Urinary Incontinence. A guide for patients”.

Further details on the Senate Inquiry can be found on the Parliament of Australia website here.

Transvaginal Mesh Care Pathways

The Australian Commission on Safety and Quality in Health Care (ACSQHC) has provided the following documents.

For Patients

Treatment options for Pelvic Organ Prolapse-Patient Information
Treatment options for complications of transvaginal mesh-Patient Information
Treatment options for stress urinary incontinence-Patient Information

For GPs

Care pathway for the management and referral of transvaginal mesh complications-GP Information
Care pathway for the management and referral of Pelvic Organ Prolapse (POP)-GP Information
Care pathway for the management and referral of urinary incontinence in women-GP Information

For Specialists

Care pathway for the management of Pelvic Organ Prolapse (POP)-Specialist information
Care pathway for the management of Stress Urinary Incontinence (SUI)-Specialist information